In January 2024, Sciwind Biosciences announced positive interim results from the first four cohorts of a Phase I clinical trial of oral ecnoglutide (XW004)
Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease
Secondary enzymes such as thioredoxins (TRXs), thioredoxin reductases (TRRs), peroxidases (PRXs), and glutaredoxins (GRXs) further bolster antioxidant defenses
[149] Derived from Table 2 available on [150] History [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
But this is an emerging area so its optimal use has yet to be established